Selected Publications
Contribution of chapters, concerning the absorption, distribution, metabolism, excretion, and genetics of several drugs, for Some Drugs and Herbal Products, Volume 108, Monograph of the International Agency for Research on Cancer (IARC). Working Group Members: B W Stewart (Australia); R J Biggar (Australia); D W Lachenmeier (Germany); S Singh (India); H Tsuda (Japan); B Baguley (New Zealand); M M Marques (Portugal); C-H Tseng (Taiwan, China); T L Knight (UK); F A Beland, J M Betz, E J Carcache de Blanco, M L Cunningham, J K Dunnick, L Guo, C W Jameson, M Karagas, R M Lunn, D L McCormick, S Singh, K L Witt, S Zhou (USA). Book publication, 2016 ISBN 1017 1606, On-line publication, 15 September 2015.
Jaakkola, J. J. K. and Knight, T. L. The Role of Exposure to Phthalates from Polyvinyl Chloride Products in the Development of Asthma and Allergies: A Systematic Review and Meta-analysis.
Environmental Health Perspectives 116(7): 845 – 53 (2008).
Meads, C., Knight, T., Hyde, C. and Wilson, J. Systematic Review of the Clinical Effectiveness and Cost Effectiveness of Antibiotic Regimens for Pelvic Inflammatory Disease.
West Midlands Health Technology Assessment Collaboration (2004).
Hidalgo, B. P., Knight, T., Burls, A. A Systematic Review of Effectiveness and Cost Effectiveness of Tacrolimus Ointment for Topical Treatment of Atopic Dermatitis in Adults and Children.
West Midlands Health Technology Assessment (HTA) Collaboration (2003).
Poolsup, N., Li Wan Po, A. and Knight, T. L.: Pharmacogenetics and psychopharmacotherapy.
Journal of Clinical Pharmacy and Therapeutics 25: 197 – 220 (2000).
Knight, T. L., Scatchard, K. M., van Pelt, F. N. A. M., and Kenna, J. G.: Sera from patients with halothane hepatitis contain antibodies to a halothane-induced liver antigen which is not detectable by immunoblotting. Journal of Pharmacology and Experimental Therapeutics. 270(3): 1325 – 1333 (1994).
Kenna, J. G., Knight, T. L. and van Pelt, F. N. A. M.: Immunity to halothane metabolite-modified proteins in halothane hepatitis. Annals of New York Academy of Science. 685: 646 – 661 (1993).
van Pelt, F. N. A. M., Knight, T. L. and Kenna, J. G.: Generation of trifluoroacetylated protein antigens in cultured rat hepatocytes exposed to halothane in vitro. Toxicology In Vitro (1993).
Conference Communications
The GEC Programme at Birmingham Medical School-an Overview. Zvauya, R., Griffiths, C., Priestman, A., Knight, T., Stephenson, M. Presented at the 3rd UK Conference on ‘Graduate Entry Medicine : What’s working?’ at University of Nottingham, July, 2006.
A Systematic Review: The Effects on Health of Individuals Living or Working in the Vicinity of a Landfill Site. Knight,T.L., Kibble,A.J., Saunders, P.J. Chemical Hazards & Poisons Division (Bham) Health Protection Agency. Presented by Poster at the Health Protection Agency Annual Conference at University of Warwick, September, 2004.
Expression of halothane-induced antigens in cultured hepatocytes. Knight, T.L. and Kenna, J.G.
Presented at The British Toxicology Society (BTS) Congress at Canterbury University, April, 1993, and awarded the annual BTS prize.
Serum from patients with halothane hepatitis contain antibodies to halothane-induced antigens not detectable by
immunoblotting.
Knight, T.L, Kenna, J.G.
Presented at the Falk Symposium No. 70. ‘Immunology and Liver’ in Basel, Switzerland, October, 1992.